The recent arrival of this new formulation represents a potentially significant advancement in the treatment of type 2 diabetes . This drug builds upon the prior success of lower strengths , showing promising results in lowering blood glycemic control and promoting weight reduction . Clinicians are assessing its complete benefit on heart outcomes a